EÇErdem Çokluk

Erdem Çokluk

*This is an algorithmically generated author record based on publicly available information.

Erdem Çokluk has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Yusufhan Yazir

    Department of Stem Cell, Institute of Health Sciences, Kocaeli University, 41001, Kocaeli, Turkey

    2 shared publications
  • Özcan Budak

    Department of Histology and Embryology, Faculty of Medicine, Sakarya University, Sakarya, Turkey (Türkiye); Sakarya University, Adapazari, Turkey, Turkey (Türkiye)

    2 shared publications
  • Elvan Şahin

    Department of Histology and Embryology, Faculty of Medicine, Sakarya University, Sakarya, Turkey (Türkiye); Histology and Embryology, Sakarya University, Adapazarı, Türkiye, Turkey (Türkiye)

    1 shared publication
  • Erdal Yılmaz

    Department of Obstetrics and Gynecology, Sakarya Training and Research Hospital, Adapazarı, Türkiye, Turkey (Türkiye)

    1 shared publication
  • Fatıma Betül Tuncer

    Department of Biochemistry Medical Faculty Sakarya University Sakarya Turkey

    1 shared publication
  • Hüseyin Çakıroğlu

    Experimental Medicine Research and Application Center Sakarya University Sakarya Turkey

    1 shared publication

Latest Publications

  • Open Access

    Protective Effects of Astaxanthin on IVF-Related Outcomes in Experimental Ovarian Torsion–Detorsion: An Experimental Animal Study

    by Özcan Budak, Sultan Canan, Hüseyin Çakıroğlu, Erdem Çokluk, Murat Coşkun, Mehmet Sühha Bostancı, Yusufhan Yazır

    This study aimed to evaluate the effects of astaxanthin on ovarian reserve, histopathological injury, oocyte maturation, fertilization, and early embryo development in rat models of ovarian ischemia and ischemia–reperfusion. In this randomized controlled experimental study, 48 adult female Sprague–Dawley rats were equally allocated to six groups undergoing sham surgery, ischemia, or ischemia–reperfusion, with or without intraperitoneal astaxanthin administration. Two male rats were used for in vitro fertilization. Following ovarian hyperstimulation, serum anti-Müllerian hormone (AMH) concentrations, ovarian histopathology, Caspase-3 expression, oocyte maturation, fertilization, and embryo development were evaluated. Astaxanthin significantly increased total and metaphase II oocyte counts, fertilized oocytes, and two-cell embryos in both ischemia and ischemia–reperfusion groups, as well as Grade 1 embryos in the ischemia–reperfusion group. Astaxanthin also reduced hemorrhage, edema, necrotic cell damage, inflammatory cell infiltration, and Caspase-3 expression. Furthermore, astaxanthin attenuated the injury-associated decline in serum AMH concentrations. No significant reproductive or histopathological changes were observed in astaxanthin-treated sham-operated rats. Astaxanthin administered before torsion or detorsion improved reproductive outcomes and reduced ovarian tissue injury, suggesting a protective effect that warrants further investigation before clinical translation.

  • Open Access

    Melatonin Partially Preserves the In Vitro Fertilizing Capacity of Spermatozoa and Blastocyst Development After Testicular Ischemia and Ischemia/Reperfusion Injury in Rats

    by Özcan Budak, Mehmet Sühha Bostancı, Erdal Yılmaz, Melih Demir, Erdem Çokluk, Hüseyin Çakıroğlu, Osman Köse, Elvan Şahin, Yusufhan Yazır

    Testicular torsion mainly affects children and adolescents, and the ischemia/reperfusion (I/R) injury that follows surgical detorsion can impair later fertility. Melatonin studies in this setting have used histological, hormonal, and semen endpoints, which cannot show whether the spermatozoa can still fertilize oocytes and support embryo development. Forty-eight male Wistar rats were assigned to sham, sustained ischemia (I), and I/R (720° torsion for 90 min, then detorsion) groups, each with or without a single intraperitoneal dose of melatonin (10 mg/kg; n = 8/group). After 20 days, testes were evaluated by Johnsen scoring and caspase-3 immunohistochemistry, serum testosterone was measured, and epididymal spermatozoa were analyzed and used for in vitro fertilization (IVF) of pooled oocytes from superovulated females. Both injuries lowered Johnsen scores, testosterone, and sperm concentration, motility, and normal morphology and increased caspase-3 immunoreactivity, with sustained ischemia causing greater damage. Fertilization fell from 55.0% in sham animals to 10.0% (I) and 15.0% (I/R), and blastocyst yield from 35.0% of inseminated oocytes to 2.5% and 7.5%, respectively. Melatonin improved all parameters, increasing fertilization to 30.0% (I+MLT) and 35.0% (I/R+MLT) and blastocyst yield to 17.5% and 25.0%, although most values remained below sham levels. A single melatonin dose therefore partially preserves the fertilizing and embryo-supporting capacity of spermatozoa after testicular ischemic injury.

  • Investigation of the effect of melatonin administration on inflammatory mediators; MMP‐2, TGF‐β and VEGF levels in rats with sepsis

    by Erdem Çokluk, Songül Doğanay, Mehmet Ramazan Şekeroğlu, Fatıma Betül Tuncer, Hüseyin Çakıroğlu, Meltem Boz

    Aims Sepsis causes life-threatening tissue and organ dysfunctions caused by endogenous mediators in response to infection. Melatonin is a powerful endogenous anti-inflammatory agent and effective in reducing cellular damage. This study aimed to evaluate the changes in serum and liver tissue levels of VEGF, TGF-β and MMP-2 in melatonin treated septic rats. Materials and methods 21 Wistar-albino male rats were included in this study. Rats were randomly divided into 3 groups. Group 1 is sham-operated control (C) group, Group 2 is cecal ligation and puncture (CLP) group and Group 3 is melatonin-treated (10mg/kg) (M-CLP) group. Serum and tissue samples were analyzed. All procedures were carried out according to the ethical rules specified in Helsinki Declaration. Results Sera MMP-2 levels were found higher than tissue MMP-2 levels in C and CLP (respectively, p=0.048, p=0.01). In CLP and M-CLP, serum TGF-β levels were higher than tissue TGF-β levels(respectively, p=0.05,p=0.01). Serum VEGF levels in CLP were found to be significantly higher than both C and M-CLP(p<0.01) Conclusion MMP-2 levels may have increased due to the prevention of oxidative damage in sepsis, and this may increase the anti-inflammatory effect. Melatonin treatment may have therapeutic effect against sepsis since it prevents the increase in serum VEGF level. A powerful endogenous antioxidant, may be a promising therapeutic agent on the mortality and morbidity of the disease, due to its lowering effect on serum VEGF, which is a poor prognostic factor in sepsis